Review article
All about blinatumomab: the bispecific T cell engager immunotherapy for B cell acute lymphoblastic leukemia
Reza Mirfakhraiea,b, Bentolhoda Kuhestani Dehaghia, Mahmoud Dehghani Ghorbic, Haniyeh Ghaffari-Nazaria, Mozhdeh Mohammadiana,d, Maryam Salimia,e, Maria Tavakoli Ardakanif, Sayeh Parkhideha,
Autor para correspondência
s.parkhideh@sbmu.ac.ir
Corresponding author at: Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran P.O. Box: 1985711151, Iran.
Corresponding author at: Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran P.O. Box: 1985711151, Iran.
a Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
b Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
c Department of Internal Medicine, Imam Hossein Hospital, School of Medicine Shahid Beheshti University of Medical Science, Tehran, Iran
d Department of Hematology and Cell Therapy, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
e Department of Biology and Anatomical Sciences, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
f Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Lido
1363
Vezesque se leu este artigo
373
Total PDF
990
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2024 Maio | 95 | 31 | 126 |
| 2024 Abril | 147 | 29 | 176 |
| 2024 Março | 184 | 56 | 240 |
| 2024 Fevereiro | 119 | 34 | 153 |
| 2024 Janeiro | 176 | 38 | 214 |
| 2023 Dezembro | 86 | 40 | 126 |
| 2023 Novembro | 71 | 35 | 106 |
| 2023 Outubro | 42 | 42 | 84 |
| 2023 Setembro | 43 | 33 | 76 |
| 2023 Agosto | 27 | 35 | 62 |
